SCHEMBL15059014

SCHEMBL15059014

O=C(O)C(=O)CCCCCCCCO

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.62
FFAR1 O14842 1/20 0.62
FFAR4 Q5NUL3 1/20 0.62
FNTA P49354 1/20 0.52
FNTB P49356 1/20 0.52
OR51E2 Q9H255 2/20 0.46
MAPK1 P28482 1/20 0.46
SLC13A3 Q8WWT9 1/20 0.46
EGLN1 Q9GZT9 1/20 0.46
CAMK2A Q9UQM7 1/20 0.46
KDM4E B2RXH2 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
LMNA P02545 3/20 0.43
TSHR P16473 1/20 0.43
NFKB1 P19838 1/20 0.43
PMP22 Q01453 1/20 0.43
CES2 O00748 4/20 0.42
CES1 P23141 4/20 0.42
HAO1 Q9UJM8 1/20 0.41
HDAC3 O15379 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16295160 1.00 GPR84 (0.62) GPR84FFAR1FFAR4FNTAFNTB
SCHEMBL8674293 1.00 GPR84 (0.62) GPR84FFAR1FFAR4FNTAFNTB
SCHEMBL9285313 1.00 GPR84 (0.62) GPR84FFAR1FFAR4FNTAFNTB
SCHEMBL801323 0.97 GPR84 (0.57) GPR84FFAR1FFAR4FNTAFNTB
SCHEMBL59985 0.88
SCHEMBL10958653 0.88 OR51E2 (0.56) GPR84FFAR1FFAR4OR51E2MAPK1
SCHEMBL10957816 0.88 OR51E2 (0.56) GPR84FFAR1FFAR4OR51E2MAPK1
SCHEMBL10961559 0.88 OR51E2 (0.56) GPR84FFAR1FFAR4OR51E2MAPK1
SCHEMBL10959418 0.88 OR51E2 (0.56) GPR84FFAR1FFAR4OR51E2MAPK1
SCHEMBL10961683 0.88 OR51E2 (0.56) GPR84FFAR1FFAR4OR51E2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210403410-A1 OPHTHALMIC FORMULATION WESTERN SYDNEY UNIV (AU) 2021-12-30 US disclosed
US-20200190015-A1 OPHTHALMIC FORMULATION WESTERN SYDNEY UNIV (AU) 2020-06-18 US disclosed
US-10385003-B2 Ophthalmic formulation MILLAR THOMAS (AU) 2019-08-20 US disclosed
EP-3459929-A1 OPHTHALMIC FORMULATION University of Western Sydney (AU) 2019-03-27 EP disclosed
EP-2794550-B1 OPHTHALMIC FORMULATION UNIV OF WESTERN SYDNEY (AU) 2019-02-20 EP disclosed
US-20140377335-A1 OPHTHALMIC FORMULATION UNIV WESTERN SYDNEY (AU) 2014-12-25 US disclosed
EP-2794550-A2 OPHTHALMIC FORMULATION University of Western Sydney (AU) 2014-10-29 EP disclosed
WO-2013091020-A2 OPHTHALMIC FORMULATION UNIVERSITY OF WESTERN SYDNEY (AU) 2013-06-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200190015-A1 OPHTHALMIC FORMULATION C9, C1R, F12 GPR84 1353/4885FFAR1 290/4885FFAR4 787/4885
US-10385003-B2 Ophthalmic formulation C9, C1R, C1S GPR84 1353/4885FFAR1 302/4885FFAR4 734/4885
US-20140377335-A1 OPHTHALMIC FORMULATION C9, C1R, C1S GPR84 1353/4885FFAR1 302/4885FFAR4 734/4885
US-20210403410-A1 OPHTHALMIC FORMULATION C9, C1R, C5 GPR84 2196/4885FFAR1 470/4885FFAR4 753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.